acetyl-l-carnitine hepatic encephalopathy randomized trial doi L-carnitine reduces ammonia levels and alleviates covert encephalopathy: A Carnitine metabolic disorders and novel

Every IV formula we use is compounded in certified sterile facilities. This safety-first approach allows even sensitive MCAS patients to pursue IV therapy with confidence

Addressing the high and rising global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): from the growing prevalence to payors perspective

136,194,368 In addition, D34-919, an inhibitor of pyruvate kinase by ALDH1A3, suppresses downstream XRCC1 lactylation, reversing chemoradiotherapy resistance in patients with high ALDH1A3-expressing GBM

Sah NK, Munshi A, Hobbs M, Carter BZ, Andreeff M , Meyn RE